Adherence of self-monitoring of blood glucose in persons with type 1 diabetes in Sweden

BMJ Open Diabetes Research and Care

Volumn 5, Issue 1, 2017, Pages

  Moström, Peter ^a   Ahlén, Elsa ^b,c,d   Imberg, Henrik ^e,f   Hansson, Per Olof ^d   Lind, Marcus ^c,d  

^a Department of Internal Medicine ^*  (Sweden)

^b Värnamo Hospital   (Sweden)

^c NU Hospital Organization   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e Statistiska Konsultgruppen   (Sweden)

^f CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CONSCIOUSNESS; CROSS-SECTIONAL STUDY; DISEASE REGISTRY; DOCTOR PATIENT RELATION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; QUESTIONNAIRE; SELF MONITORING; SWEDEN; TREATMENT REFUSAL;

EID: 85017218547     PISSN: None     EISSN: 20524897     Source Type: Journal    
DOI: 10.1136/bmjdrc-2016-000342     Document Type: Article

References (29)

1. Lind M, Svensson AM, Rosengren A. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med 2015;372:880–1.
2. Ahlén E, Pivodic A, Wedel H, et al. Glycemic control, renal complications, and current smoking in relation to excess risk of mortality in persons with type 1 diabetes. J Diabetes Sci Technol 2016;10:1006–14.
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med 1993;329:977–86.
4. Karter AJ, Ackerson LM, Darbinian JA, et al. Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry. Am J Med 2001;111:1–9.
5. Schütt M, Kern W, Krause U, et al. Is the frequency of self-monitoring of blood glucose related to long-term metabolic control? Multicenter analysis including 24,500 patients from 191 centers in Germany and Austria. Exp Clin Endocrinol Diabetes 2006;114:384–8.
6. Hansen MV, Pedersen-Bjergaard U, Heller SR, et al. Frequency and motives of blood glucose self-monitoring in type 1 diabetes. Diabetes Res Clin Pract 2009;85:183–8.
7. Miller KM, Beck RW, Bergenstal RM, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care 2013;36:2009–14.
8. Evans JM, Newton RW, Ruta DA, et al. Frequency of blood glucose monitoring in relation to glycaemic control: observational study with diabetes database. BMJ 1999;319:83–6.
9. Ziegler R, Heidtmann B, Hilgard D, et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes. Pediatr Diabetes 2011;12:11–17.
10. American Diabetes Association. Standards of medical care in diabetes--2014. Diabetes Care 2014;37(Suppl 1):S14–80.
11. Attvall S. Egenmätning av blodglukos vid diabetes_2013.pdf [Internet]. [cited 2017 Feb 19]. Available from: http://epi.vgregion.se/upload/L%C3%A4kemedel/L%C3%A4kemedelskommitt%C3%A9n/ Substans/RMR%20Blodglukos_2013.pdf
12. Peyrot M, Rubin RR, Lauritzen T, et al. Psychosocial problems and barriers to improved diabetes management: results of the Cross-National Diabetes Attitudes, Wishes and Needs (DAWN) study. Diabet Med 2005;22:1379–85.
13. Vincze G, Barner JC, Lopez D. Factors associated with adherence to self-monitoring of blood glucose among persons with diabetes. Diabetes Educ 2004;30:112–25.
14. Thomas D, Elliott EJ. Low glycaemic index, or low glycaemic load, diets for diabetes mellitus. Cochrane Database Syst Rev 2009(1): CD006296.
15. Siebenhofer A, Plank J, Berghold A, et al. Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev 2006(2):CD003287.
16. Baumeister H, Hutter N, Bengel J. Psychological and pharmacological interventions for depression in patients with diabetes mellitus: an abridged Cochrane review. Diabet Med J Br Diabet Assoc 2014;31:773–86.
17. Misso ML, Egberts KJ, Page M, et al. Continuous subcutaneous insulin infusion (CSII) versus multiple insulin injections for type 1 diabetes mellitus. Cochrane Database Syst Rev 2010(1):CD005103.
18. Breton MD, Kovatchev BP. Impact of blood glucose self-monitoring errors on glucose variability, risk for hypoglycemia, and average glucose control in type 1 diabetes: an in silico study. J Diabetes Sci Technol 2010;4:562–70.
19. Klonoff DC, Prahalad P. Performance of cleared blood glucose monitors. J Diabetes Sci Technol 2015;9:895–910.
20. Landin-Olsson M. Vägledning vid upphandling av plasmaglukosmätarsystem - pr001_vaegledning-vid-upphandling-avplasmaglukosmaetarsystem_ 2014-03-31.pdf [Internet]. [cited 2017 Feb 17]. Available from: http://www.equalis.se/media/93730/pr001_vaegledning-vid-upphandling-av-plasmaglukosmaetarsystem_2014-03-31.pdf
21. Wambui Charity K, Kumar AMV, Hinderaker SG, et al. Do diabetes mellitus patients adhere to self-monitoring of blood glucose (SMBG) and is this associated with glycemic control? Experiences from a SMBG program in western Kenya. Diabetes Res Clin Pract 2016;112:37–43.
22. Courtenay WH. Constructions of masculinity and their influence on men’s well-being: a theory of gender and health. Soc Sci Med 1982 2000;50:1385–401.
23. Heinemann L. Finger pricking and pain: a never ending story. J Diabetes Sci Technol 2008;2:919–21.
24. Battelino T, Phillip M, Bratina N, et al. Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes. Diabetes Care 2011;34:795–800.
25. Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med 2010;363:311–20.
26. Conget I, Battelino T, Giménez M, et al. The SWITCH study (sensing with insulin pump therapy to control HbA(1c)): design and methods of a randomized controlled crossover trial on sensor-augmented insulin pump efficacy in type 1 diabetes suboptimally controlled with pump therapy. Diabetes Technol Ther 2011;13:49–54.
27. An Evaluation of Novel Glucose Sensing Technology on Hypoglycaemia in Type 1 Diabetes (IMPACT)—Tabular View— ClinicalTrials.gov [Internet]. (cited 2016 Mar 14). https://clinicaltrials.gov/ct2/show/record/NCT02232698.
28. Guðbjörnsdóttir S. Arsrapport_NDR_2014.pdf [Internet]. [cited 2017 Feb 19]. Available from: https://www.ndr.nu/pdfs/Arsrapport_NDR_2014.pdf
29. Patton SR. Adherence to glycemic monitoring in diabetes. J Diabetes Sci Technol 2015;9:668–75.